AF患者-话题@MedSci - 梅斯（MedSci）

#AF患者#

16篇内容 | 669人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1779455, encodeId=75021e79455bf, content=<a href='/topic/show?id=09a8208303' target=_blank style='color:#2F92EE;'>#AF患者#</a>, objectTitle=J Clin Med：艾多沙班在韩国和中国台湾AF患者中的疗效分析, objectType=article, longId=293583, objectId=cda32935831e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cda32935831e, replyNumber=0, likeNumber=97, createdTime=2022-08-18, rootId=0, userName=zhmscau, userId=2e94174, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cda32935831e, moduleTitle=J Clin Med：艾多沙班在韩国和中国台湾AF患者中的疗效分析, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=cda32935831e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1779454, encodeId=5ba21e79454a1, content=<a href='/topic/show?id=09a8208303' target=_blank style='color:#2F92EE;'>#AF患者#</a>, objectTitle=Front Cardiovasc Med：HAS-BLED评分对AF患者出血风险的预测分析, objectType=article, longId=265042, objectId=520e2650423e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=520e2650423e, replyNumber=0, likeNumber=117, createdTime=2022-03-04, rootId=0, userName=zhmscau, userId=2e94174, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=520e2650423e, moduleTitle=Front Cardiovasc Med：HAS-BLED评分对AF患者出血风险的预测分析, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=520e2650423e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1779453, encodeId=05001e7945352, content=<a href='/topic/show?id=09a8208303' target=_blank style='color:#2F92EE;'>#AF患者#</a>, objectTitle=Eur Heart J：AF患者PCI后抗血栓治疗，双重还是三重？, objectType=article, longId=141257, objectId=772c14125e23, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=772c14125e23, replyNumber=0, likeNumber=77, createdTime=2018-11-16, rootId=0, userName=zhmscau, userId=2e94174, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=772c14125e23, moduleTitle=Eur Heart J：AF患者PCI后抗血栓治疗，双重还是三重？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=772c14125e23)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1779452, encodeId=bc8e1e7945293, content=<a href='/topic/show?id=09a8208303' target=_blank style='color:#2F92EE;'>#AF患者#</a>, objectTitle=JACC：NOAC增加NVAF患者重度肝损伤风险？, objectType=article, longId=134602, objectId=aa8d134602c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aa8d134602c2, replyNumber=0, likeNumber=63, createdTime=2019-02-05, rootId=0, userName=zhmscau, userId=2e94174, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aa8d134602c2, moduleTitle=JACC：NOAC增加NVAF患者重度肝损伤风险？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=aa8d134602c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1779449, encodeId=f3ed1e7944987, content=<a href='/topic/show?id=09a8208303' target=_blank style='color:#2F92EE;'>#AF患者#</a>, objectTitle=J Manag Care Spec Pharm：阿哌沙班vs华法林对老年NVAF患者HCRU和成本的影响, objectType=article, longId=127098, objectId=601912e0989c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=601912e0989c, replyNumber=0, likeNumber=86, createdTime=2018-05-23, rootId=0, userName=zhmscau, userId=2e94174, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=601912e0989c, moduleTitle=J Manag Care Spec Pharm：阿哌沙班vs华法林对老年NVAF患者HCRU和成本的影响, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=601912e0989c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1779451, encodeId=18291e79451dc, content=<a href='/topic/show?id=09a8208303' target=_blank style='color:#2F92EE;'>#AF患者#</a>, objectTitle=Thromb Haemostasis：糖尿病AF患者哪种抗凝药是当之无愧的王者？, objectType=article, longId=131248, objectId=2c461312480c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2c461312480c, replyNumber=0, likeNumber=77, createdTime=2018-04-09, rootId=0, userName=医者仁心, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2c461312480c, moduleTitle=Thromb Haemostasis：糖尿病AF患者哪种抗凝药是当之无愧的王者？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=2c461312480c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1779450, encodeId=38601e7945043, content=<a href='/topic/show?id=09a8208303' target=_blank style='color:#2F92EE;'>#AF患者#</a>, objectTitle=J Intern Med：使用标准剂量和低剂量NOAC的AF患者卒中风险无差异？, objectType=article, longId=128539, objectId=09e4128539e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=09e4128539e7, replyNumber=0, likeNumber=70, createdTime=2018-12-17, rootId=0, userName=zhmscau, userId=2e94174, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=09e4128539e7, moduleTitle=J Intern Med：使用标准剂量和低剂量NOAC的AF患者卒中风险无差异？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=09e4128539e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1779448, encodeId=91751e7944844, content=<a href='/topic/show?id=09a8208303' target=_blank style='color:#2F92EE;'>#AF患者#</a>, objectTitle=J Manag Care Spec Pharm：未使用OAC的新确诊NVAF患者使用达比加群还是华法林更划算？, objectType=article, longId=127093, objectId=29fd12e093c0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=29fd12e093c0, replyNumber=0, likeNumber=76, createdTime=2018-11-19, rootId=0, userName=zhmscau, userId=2e94174, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=29fd12e093c0, moduleTitle=J Manag Care Spec Pharm：未使用OAC的新确诊NVAF患者使用达比加群还是华法林更划算？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=29fd12e093c0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1779445, encodeId=03831e7944529, content=<a href='/topic/show?id=09a8208303' target=_blank style='color:#2F92EE;'>#AF患者#</a>, objectTitle=Mayo Clin Proc：AF患者遵照指南抗血栓好处多多！, objectType=article, longId=111531, objectId=0b53111531d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0b53111531d5, replyNumber=0, likeNumber=148, createdTime=2017-11-27, rootId=0, userName=zhmscau, userId=2e94174, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0b53111531d5, moduleTitle=Mayo Clin Proc：AF患者遵照指南抗血栓好处多多！, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=0b53111531d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1779447, encodeId=4c021e794471a, content=<a href='/topic/show?id=09a8208303' target=_blank style='color:#2F92EE;'>#AF患者#</a>, objectTitle=【AHA 2017】中国学者：预测AF患者1年缺血性卒中及血栓栓塞的风险模型——中国AF注册登记研究, objectType=article, longId=121217, objectId=d14312121e92, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d14312121e92, replyNumber=0, likeNumber=83, createdTime=2018-07-17, rootId=0, userName=zhmscau, userId=2e94174, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d14312121e92, moduleTitle=【AHA 2017】中国学者：预测AF患者1年缺血性卒中及血栓栓塞的风险模型——中国AF注册登记研究, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=d14312121e92)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1779446, encodeId=1e0f1e794463a, content=<a href='/topic/show?id=09a8208303' target=_blank style='color:#2F92EE;'>#AF患者#</a>, objectTitle=Ann Pharmacother：NVAF患者使用DOAC治疗影响剂量合理性的是什么？, objectType=article, longId=113647, objectId=cd1611364e27, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cd1611364e27, replyNumber=0, likeNumber=79, createdTime=2017-10-27, rootId=0, userName=zhmscau, userId=2e94174, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cd1611364e27, moduleTitle=Ann Pharmacother：NVAF患者使用DOAC治疗影响剂量合理性的是什么？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=cd1611364e27)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1779443, encodeId=a4c61e7944331, content=<a href='/topic/show?id=09a8208303' target=_blank style='color:#2F92EE;'>#AF患者#</a>, objectTitle=Heart：抗凝治疗的AF患者：非重大出血不应轻视！, objectType=article, longId=98233, objectId=223c982337e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=223c982337e, replyNumber=0, likeNumber=74, createdTime=2017-12-15, rootId=0, userName=zhmscau, userId=2e94174, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=223c982337e, moduleTitle=Heart：抗凝治疗的AF患者：非重大出血不应轻视！, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=223c982337e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1779444, encodeId=a1ab1e7944435, content=<a href='/topic/show?id=09a8208303' target=_blank style='color:#2F92EE;'>#AF患者#</a>, objectTitle=JAMA Intern Med：AF患者出血性脑卒中或外伤性颅内出血后恢复使用华法林结局各异？, objectType=article, longId=99393, objectId=b66c9939334, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b66c9939334, replyNumber=0, likeNumber=83, createdTime=2017-12-28, rootId=0, userName=zhmscau, userId=2e94174, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b66c9939334, moduleTitle=JAMA Intern Med：AF患者出血性脑卒中或外伤性颅内出血后恢复使用华法林结局各异？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=b66c9939334)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1779440, encodeId=a86d1e79440f5, content=<a href='/topic/show?id=09a8208303' target=_blank style='color:#2F92EE;'>#AF患者#</a>, objectTitle=JACC：在AF患者中，糖尿病病程是预测缺血性卒中的指标, objectType=article, longId=62266, objectId=1fb762266ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1fb762266ef, replyNumber=0, likeNumber=88, createdTime=2016-10-22, rootId=0, userName=zhmscau, userId=2e94174, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1fb762266ef, moduleTitle=JACC：在AF患者中，糖尿病病程是预测缺血性卒中的指标, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=1fb762266ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1779441, encodeId=02231e7944151, content=<a href='/topic/show?id=09a8208303' target=_blank style='color:#2F92EE;'>#AF患者#</a>, objectTitle=Stroke：新的方法可改善预测AF患者发生心源性猝中的风险, objectType=article, longId=62505, objectId=d1b96250561, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d1b96250561, replyNumber=0, likeNumber=95, createdTime=2016-08-23, rootId=0, userName=zhmscau, userId=2e94174, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d1b96250561, moduleTitle=Stroke：新的方法可改善预测AF患者发生心源性猝中的风险, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=d1b96250561)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1779442, encodeId=df6d1e7944251, content=<a href='/topic/show?id=09a8208303' target=_blank style='color:#2F92EE;'>#AF患者#</a>, objectTitle=Ann Med：AF患者合并抑郁或焦虑，死亡率较高, objectType=article, longId=62678, objectId=d02d626e8ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d02d626e8ba, replyNumber=0, likeNumber=67, createdTime=2016-07-13, rootId=0, userName=zhmscau, userId=2e94174, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d02d626e8ba, moduleTitle=Ann Med：AF患者合并抑郁或焦虑，死亡率较高, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=d02d626e8ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

AF患者

2020-05-29

zhmscau (审核中...)

前往app查看评论内容

#AF患者#

J Clin Med：艾多沙班在韩国和中国台湾AF患者中的疗效分析

2022-08-18

zhmscau (审核中...)

前往app查看评论内容

#AF患者#

Front Cardiovasc Med：HAS-BLED评分对AF患者出血风险的预测分析

2022-03-04

zhmscau (审核中...)

前往app查看评论内容

#AF患者#

Eur Heart J：AF患者PCI后抗血栓治疗，双重还是三重？

2018-11-16

zhmscau (审核中...)

前往app查看评论内容

#AF患者#

JACC：NOAC增加NVAF患者重度肝损伤风险？

2019-02-05

zhmscau (审核中...)

前往app查看评论内容

#AF患者#

J Manag Care Spec Pharm：阿哌沙班vs华法林对老年NVAF患者HCRU和成本的影响

2018-05-23

医者仁心 (审核中...)

前往app查看评论内容

#AF患者#

Thromb Haemostasis：糖尿病AF患者哪种抗凝药是当之无愧的王者？

2018-04-09

zhmscau (审核中...)

前往app查看评论内容

#AF患者#

J Intern Med：使用标准剂量和低剂量NOAC的AF患者卒中风险无差异？

2018-12-17

zhmscau (审核中...)

前往app查看评论内容

#AF患者#

J Manag Care Spec Pharm：未使用OAC的新确诊NVAF患者使用达比加群还是华法林更划算？

2018-11-19

zhmscau (审核中...)

前往app查看评论内容

#AF患者#

Mayo Clin Proc：AF患者遵照指南抗血栓好处多多！

2017-11-27

zhmscau (审核中...)

前往app查看评论内容

#AF患者#

【AHA 2017】中国学者：预测AF患者1年缺血性卒中及血栓栓塞的风险模型——中国AF注册登记研究

2018-07-17

zhmscau (审核中...)

前往app查看评论内容

#AF患者#

Ann Pharmacother：NVAF患者使用DOAC治疗影响剂量合理性的是什么？

2017-10-27

zhmscau (审核中...)

前往app查看评论内容

#AF患者#

Heart：抗凝治疗的AF患者：非重大出血不应轻视！

2017-12-15

zhmscau (审核中...)

前往app查看评论内容

#AF患者#

JAMA Intern Med：AF患者出血性脑卒中或外伤性颅内出血后恢复使用华法林结局各异？

2017-12-28

zhmscau (审核中...)

前往app查看评论内容

#AF患者#

JACC：在AF患者中，糖尿病病程是预测缺血性卒中的指标

2016-10-22

zhmscau (审核中...)

前往app查看评论内容

#AF患者#

Stroke：新的方法可改善预测AF患者发生心源性猝中的风险

2016-08-23

zhmscau (审核中...)

前往app查看评论内容

#AF患者#

Ann Med：AF患者合并抑郁或焦虑，死亡率较高

2016-07-13

科室
- - 订阅+
  - 更多科室
工具
服务